drug

telotristat ethyl

Marketedupdated 2mo ago

by TerSera Therapeutics LLC

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

Patent cliff

source: FDA Orange Book

first barrier falls

Dec 11, 2027

~1.4 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (5)

Feb 28, 2031compositionUS 77094934.6y
Feb 27, 2031compositionUS 81932044.6y
Dec 19, 2028method-of-use (U-1979)US 86530942.5y
Dec 11, 2027compositionUS 75538401.4y
Dec 11, 2027method-of-use (U-1979)US 79685591.4y

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Trials studying telotristat ethyl

phase2Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancercompletedn=23
—Real-world Evidence Study EvaLuating PAtient-Reported Outcomes With XERMELOcompletedn=223